[edited by Jacob Boe, B. Ronan O'Driscoll, and John H. Dennis].
London ; New York
Martin Dunitz ; Independence, KY : Distributed in the USA by Taylor & Francis
2004
(xii, 323 pages) : illustrations
Book Cover; Title; Contents; Preface; Contributors; Theory and science of nebulizer use; Quality control and standards in nebulizer performance and use; New developments in nebulizer technology; Acute asthma and COPD exacerbations; Nebulizer use in chronic asthma and obstructive airway disease; Special applications of aerosol therapy; Nebulized antibiotics in cystic fibrosis and non-CF bronchiectasis in children and adults; Nebulizers in cystic fibrosis and non-CF bronchiectasis in children and adults: therapies other than antibiotics; Diagnostic uses of nebulizers. Pediatric uses of nebulizersUse of nebulizers in primary care: issues and challenges; Practical use; Choice of nebulizer device and running a nebulizer service; Education and staff training; Summary and guidelines for use; Index.
The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of R
Nebulizer therapy
Atomizers.
Nebulizers and Vaporizers.
Respiratory therapy.
RC735
.
I5
E358
2004
[edited by Jacob Boe, B. Ronan O'Driscoll, and John H. Dennis].